Case report: Rectal adminstration of ivermectin to a patient with Strongyloides hyperinfection syndrome

American Journal of Tropical Medicine and Hygiene

Volumn 68, Issue 4, 2003, Pages 453-455

  Tarr, Philip E ^a,c   Miele, Peter S ^a   Peregoy, Kenneth S ^a   Smith, Margo A ^a   Neva, Franklin A ^b   Lucey, Daniel R ^a  

^a WASHINGTON HOSPITAL CENTER   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; ANTHELMINTIC AGENT; ENEMA; IMMUNOSUPPRESSIVE AGENT; IVERMECTIN; LAXATIVE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; ORA PLUS; PREDNISONE; RAPAMYCIN; SUSPENDING AGENT; TACROLIMUS; TIABENDAZOLE; UNCLASSIFIED DRUG; ANTINEMATODAL AGENT;

ADULT; ARTICLE; CASE REPORT; DISEASE SEVERITY; DRUG ABSORPTION; DRUG ADMINISTRATION ROUTE; DRUG RETENTION; FEMALE; HELMINTHIASIS; HUMAN; INTESTINE ABSORPTION; KIDNEY TRANSPLANTATION; NONHUMAN; OSMOLALITY; PARALYTIC ILEUS; POWDER; STRONGYLOIDES; STRONGYLOIDES HYPERINFECTION SYNDROME; STRONGYLOIDIASIS; SUPERINFECTION; SUSPENSION; IMMUNE DEFICIENCY; INTESTINE PSEUDOOBSTRUCTION; MIDDLE AGED; PATHOPHYSIOLOGY; RECTAL DRUG ADMINISTRATION; TREATMENT OUTCOME;

ORA; STRONGYLOIDES; TREMATODA;

ADMINISTRATION, RECTAL; ANTINEMATODAL AGENTS; ENEMA; FEMALE; HUMANS; IMMUNOCOMPROMISED HOST; INTESTINAL PSEUDO-OBSTRUCTION; IVERMECTIN; MIDDLE AGED; STRONGYLOIDIASIS; TREATMENT OUTCOME;

EID: 0042307252     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2003.68.453     Document Type: Article

References (24)

1. Igra-Siegman Y, Kapila R, Sen P, Kaminski ZC, Louria DB, 1981. Syndrome of hyperinfection with Strongyloides stercoralis. Rev Infect Dis 3: 397-407.
2. Scowden EB, Schaffner W, Stone WJ, 1978. Overwhelming strongyloidiasis. An unappreciated opportunistic infection. Medicine (Baltimore) 57: 527-544.
3. Mahmoud AA, 1996. Strongyloidiasis. Clin Infect Dis 23: 949-953.
4. DeVault GA Jr, King JW, Rohr MS, Landreneau MD, Brown ST III, McDonald JC, 1990. Opportunistic infections with Strongyloides stercoralis in renal transplantation. Rev Infect Dis 12: 653-657.
5. Nonaka D, Takaki K, Tanaka M, Umeno M, Takeda T, Yoshida M, Haraguch Y, Okada K, Sawae Y, 1998. Paralytic ileus due to strongyloidiasis: case report and review of the literature. Am J Trop Med Hyg 59: 535-538.
6. Milner PF, Irvine RA, Barton CJ, Bras G, Richards R, 1965. Intestinal malabsorption in Strongyloides stercoralis infection. Gut 6: 574-581.
7. Cruz T, Reboucas G, Rocha H, 1966. Fatal strongyloidiasis in patients receiving corticosteroids. N Engl J Med 275: 1093-1096.
8. Gann PH, Neva FA, Gam AA, 1994. A randomized trial of single- and two-dose ivermectin versus thiabendazole for treatment of strongyloidiasis. J Infect Dis 169: 1076-1079.
9. Marti H, Haji HJ, Savioli L, Chwaya HM, Mgeni AF, Ameir JS, Hatz C, 1996. A comparative trial of a single-dose ivermectin versus three days of albendazole for treatment of Strongyloides stercoralis and other soil-transmitted helminth infections in children. Am J Trop Med Hyg 55: 477-481.
10. Morgan JS, Schaffner W, Stone WJ, 1986. Opportunistic strongyloidiasis in renal transplant recipients. Transplantation 42: 518-524.
11. Berk SL, Verghese A, Alvarez S, Hall K, Smith B, 1987. Clinical and epidemiological features of strongyloidiasis. A prospective study in rural Tennessee. Arch Intern Med 147: 1257-1261.
12. Hoy WE, Roberts NJ, Bryson MF, Bowles C, Lee JCK, Rivero AJ, Ritterson AL, 1981. Transmission of strongyloidiasis by kidney transplant? Disseminated strongyloidiasis in both recipients of kidney allografts from a single cadaver donor. JAMA 246: 1937-1939.
13. Palau LA, Pankey GA, 1997. Strongyloides hyperinfection in a renal transplant recipient receiving cyclosporine: possible Strongyloides stercoralis transmission by kidney transplant. Am J Trop Med Hyg 57: 413-415.
14. Nolan TJ, Schad GA, 1996. Tacrolimus allows autoinfective development of the parasitic nematode Strongyloides stercoralis. Transplantation 62: 1038.
15. Schad GA, 1986. Cyclosporin may eliminate the threat of overwhelming strongyloidiasis in immunosuppressed patients. J Infect Dis 153: 178.
16. Archibald LK, Beeching NJ, Gill GV, Bailey JW, Bell Dr, 1993. Albendazole is effective treatment for chronic strongyloidiasis. Q J Med 86: 191-195.
17. Alvarez Chacon R, Rodriguez Rodriguez M, Cob Sosa CE, 1974. Evaluacion de la efectividad terapeutica del hexilresorcinol y del tiabendazol en la tricocefalosis masiva en ninos. Bol Med Hosp Infant Mex 31: 1125-1147.
18. Perez C, Menard E, Saelzer E, Atlas A, 1977. Tricocefalosis infantil masiva: experiencia en 13 casos. Rev Med Chil 105: 520-522.
19. Kennedy S, Campbell RM, Lawrence JE, Nichol GM, Rao DM, 1989. A case of severe Strongyloides stercoralis infection with jejunal perforation in an Australian ex-prisoner of war. Med J Aust 150: 92-93.
20. Thomas MC, Costello SA, 1998. Disseminated strongyloidiasis arising from a single dose of dexamethasone before stereotactic radiosurgery. Int J Clin Pract 52: 520-521.
21. Boken DJ, Leoni PA, Preheim LC, 1993. Treatment of Strongyloides stercoralis hyperinfection syndrome with thiabendazole administered per rectum. Clin Infect Dis 16: 123-126.
22. Naquira C, Jimenez G, Guerra JG, Bernal R, Nalin DR, Neu D, Aziz M, 1989. Ivermectin for human strongyloidiasis and other intestinal helminths. Am J Trop Med Hyg 40: 304-309.
23. Costa JL, Diazgranados JA, 1994. Ivermectin for spasticity in spinal-cord injury (letter). Lancet 343: 739.
24. Chiodini PL, Reid AJ, Wiselka MJ, Firmin R, Foweraker J, 2000. Parenteral ivermectin in Strongyloides hyperinfection (letter). Lancet 355: 43-44.